US 7052904
Hybrid adeno-retroviral vector for the transfection of cells
granted A61KA61K35/13A61K48/00
Quick answer
US patent 7052904 (Hybrid adeno-retroviral vector for the transfection of cells) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K35/13, A61K48/00, A61P, A61P43/00